Antigen-Specific Immune Monitoring of T-cells: Applications in infectious disease and immuno-oncology


In April, Immudex will be hosting a seminar day in Heidelberg where researchers from the area will give presentations about their research in the area of antigen-specific immune monitoring of T cells.

This event is free to attend but the number of places is limited so please register to secure your seat.

Date: 18 April 2023

Time: 9:30 – 15:00

Location: Design Offices Heidelberg Colours

Langer Anger 7-9, 69115 Heidelberg, Germany



Welcome Coffee and desk registration

Dr. Isabel Poschke, Head of Immune Monitoring Unit. German Cancer Research Center (DKFZ), Heidelberg

Next-generation immune monitoring in immuno-oncology trials – repertoires, receptors, reactivities


Dr. Viktor Umansky, Group Leader, German Cancer Research Center (DKFZ), Heidelberg and University Medical Center (UMM) Mannheim.

T cell immune responses against SARS-CoV-2 upon vaccination


Dr. Krishna Das, Principal Scientist at ViraTherapeutics GmbH, Innsbruck, Austria

Monitoring antigen-specific T cell responses for oncolytic virus therapy


Lunch & Get Together


Dr. Matilda Weywadt, Immudex ApS 

Evaluating Antigen Specificity and its Impact on Immunity using Dextramer® Technology 


Dr. Marten Mayer, Senior Scientist, Department of Medical Oncology (Prof. Dr. Dirk Jäger), National Center for Tumor Diseases (NCT), Heidelberg and Antigen Presentation & T/NK Cell Activation (PD Dr. Frank Momburg), German Cancer Research Center (DKFZ), Heidelberg 

Towards cancer neoepitope-specific TCR T cell therapy using recombinant MHC molecules


Dr. Sebastian Klein, Dept. of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology Hannover Medical School (MHH)

Single-cell sequencing of antigen-specific CD8+ T cells in chronic viral infection 

Meet the Team

Mohammad Salem, PhD

Pharma Business Development Manager

Henrik Martin Pfundheller, PhD, EBA

Chief Commercial Officer

Niels Frandsen, PhD

Global Product Manager